BioSpace News Archive

Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for Q2 2020, before the U.S. markets open on Thursday, August 6, 2020. Following the announcement, the Company will host a live teleconference and webcast at 8:00 a.m. EDT (1:00 p.m. BST) on the same day (details below). The press release and the live webcast of the con

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, will announce its second quarter 2020 financial results after market close on Thursday, August 6, 2020.

The EndBrainCancer Initiative (EBCI) announced today that it is launching a new initiative to better support patients with brain tumors and their caregivers in response to the COVID-19 crisis.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced Dr. Elizabeth Tanzi, lead investigator on Soliton’s pivotal cellulite clinical trial and member of Soliton’s Scientific Advisory Board,

RAS is the most common oncogene implicated in human cancer KRAS, HRAS or NRAS mutations are present in approximately one-third of all cancer patients

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2020 financial results and provide an update on the company’s business and outlook on Wednesday, August 5, 2020 at 4:30 p.m. (ET) after the closing of the market. The call can be access

Olema Oncology, a biopharmaceutical company developing innovative targeted therapies for women’s cancers, today announced the closing of an oversubscribed $54 million Series B financing.

NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces the execution of an Exclusive Development and Distribution Agreement with Zimmer Biomet.

Halberd Corporation (OTC PINK:HALB) announced their Chief Technical Officer and Head of Scientific Advisory Board, Dr. Patricio Reyes presented A Community Information Session virtual event hosted yesterday by the Brain Injury Alliance of Arizona, on “Covid-19 & the Nervous System; Neurological Complications That Can Result”.

Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, August 5, 2020 to report its second quarter 2020 financial results and provide a corporate update. To access the live confer